Heat Biologics   Report issue

For profit Phase 1 Phase 2
Founded: Chapel Hill NC United States (2008)

Organization Overview

First Clinical Trial
2011
NCT01504542
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Heat Biologics